# Dropbox timeline entity: /record/dropbox.md id: ent_dropbox ## undated - undated | fiscal_year_end | 12-31 | valid | [clm_0927263335AA](/claim/clm_0927263335AA.md) - undated | cik | 0001467623 | valid | [clm_82FB2DA2DA47](/claim/clm_82FB2DA2DA47.md) - undated to 2009-07-07 | registrant_name | DROPBOX, INC. | superseded | [clm_929E4BE923CA](/claim/clm_929E4BE923CA.md) - undated | ticker | DBX | valid | [clm_9F5999CB413A](/claim/clm_9F5999CB413A.md) - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_B976D05FBEC4](/claim/clm_B976D05FBEC4.md) - undated | state_of_incorporation | NV | valid | [clm_CB245390D176](/claim/clm_CB245390D176.md) - undated | headquarters | San Francisco | valid | [clm_DD095D909A9F](/claim/clm_DD095D909A9F.md) - undated | listed_on | Nasdaq | valid | [clm_DD534CBFB3BD](/claim/clm_DD534CBFB3BD.md) - undated | member_of | Internet2 | unverified | [clm_029801CD3290](/claim/clm_029801CD3290.md) - undated | founder | Drew Houston | unverified | [clm_2706873666CC](/claim/clm_2706873666CC.md) - undated | member_of | Rust Foundation | unverified | [clm_566C3AE444B9](/claim/clm_566C3AE444B9.md) - undated | website | http://www.dropbox.com | unverified | [clm_591CCE458E00](/claim/clm_591CCE458E00.md) - undated | member_of | Business Software Alliance | unverified | [clm_67CADB824F0E](/claim/clm_67CADB824F0E.md) - undated | founder | Arash Ferdowsi | unverified | [clm_6A339DBA2B8B](/claim/clm_6A339DBA2B8B.md) - undated | member_of | Internet Association | unverified | [clm_6A9C5CD9814A](/claim/clm_6A9C5CD9814A.md) ## 2007 - 2007-01-01 | founded | 2007-01-01 | unverified | [clm_6BDF7B68E651](/claim/clm_6BDF7B68E651.md) ## undated - undated | country | United States | valid | [clm_D3CC51DD5CEF](/claim/clm_D3CC51DD5CEF.md) ## 2009 - 2009-07-07 to 2009-07-07 | registrant_name | Evenflow, Inc. | superseded | [clm_40D37D37F5C6](/claim/clm_40D37D37F5C6.md) ## 2015 - 2015-12-31 to 2016-12-31 | total_equity | 185,600,000 United States dollar | superseded | [clm_1BC2801F0A7D](/claim/clm_1BC2801F0A7D.md) - 2015-12-31 to 2016-12-31 | cash_and_equivalents | 356,900,000 United States dollar | superseded | [clm_4873E67C4F2E](/claim/clm_4873E67C4F2E.md) ## 2016 - 2016-01-28 to 2016-04-01 | employees | 1,500 | superseded | [clm_17C1BE9EACED](/claim/clm_17C1BE9EACED.md) - 2016-04-01 to 2016-04-01 | employees | 1,200 | superseded | [clm_B7960EEEE6C8](/claim/clm_B7960EEEE6C8.md) - 2016-12-31 to 2017-12-31 | net_income | -210,200,000 United States dollar | superseded | [clm_2EE9A61C4CC7](/claim/clm_2EE9A61C4CC7.md) - 2016-12-31 to 2017-12-31 | total_equity | 122,800,000 United States dollar | superseded | [clm_395AFD0FEC10](/claim/clm_395AFD0FEC10.md) - 2016-12-31 to 2017-12-31 | revenue | 844,800,000 United States dollar | superseded | [clm_538F051BFA28](/claim/clm_538F051BFA28.md) - 2016-12-31 to 2017-12-31 | operating_income | -193,500,000 United States dollar | superseded | [clm_6E827E93940A](/claim/clm_6E827E93940A.md) - 2016-12-31 to 2017-03-31 | cash_and_equivalents | 352,700,000 United States dollar | superseded | [clm_A94315C7743D](/claim/clm_A94315C7743D.md) - 2016-12-31 to 2017-12-31 | research_and_development | 289,700,000 United States dollar | superseded | [clm_F6E71C5A7A93](/claim/clm_F6E71C5A7A93.md) ## 2017 - 2017-03-31 to 2017-06-30 | cash_and_equivalents | 351,200,000 United States dollar | superseded | [clm_787467C68CA2](/claim/clm_787467C68CA2.md) - 2017-03-31 to 2017-06-30 | quarterly_net_income | -33,100,000 United States dollar | superseded | [clm_85AEAFD315A7](/claim/clm_85AEAFD315A7.md) - 2017-03-31 to 2017-06-30 | quarterly_research_and_development | 89,300,000 United States dollar | superseded | [clm_A96EE57B6DB4](/claim/clm_A96EE57B6DB4.md) - 2017-03-31 to 2017-06-30 | quarterly_revenue | 247,900,000 United States dollar | superseded | [clm_BB0E0045B0F5](/claim/clm_BB0E0045B0F5.md) - 2017-03-31 to 2017-06-30 | quarterly_operating_income | -33,400,000 United States dollar | superseded | [clm_DCCBDF7E108E](/claim/clm_DCCBDF7E108E.md) - 2017-06-30 to 2017-09-30 | quarterly_research_and_development | 89,800,000 United States dollar | superseded | [clm_0E00488F4F05](/claim/clm_0E00488F4F05.md) - 2017-06-30 to 2017-09-30 | quarterly_revenue | 266,700,000 United States dollar | superseded | [clm_43CCC24E4A71](/claim/clm_43CCC24E4A71.md) - 2017-06-30 to 2017-09-30 | cash_and_equivalents | 395,700,000 United States dollar | superseded | [clm_77A8D4D65773](/claim/clm_77A8D4D65773.md) - 2017-06-30 to 2017-09-30 | quarterly_net_income | -26,800,000 United States dollar | superseded | [clm_94A775306FE8](/claim/clm_94A775306FE8.md) - 2017-06-30 to 2017-09-30 | quarterly_operating_income | -26,700,000 United States dollar | superseded | [clm_FF0B951718FB](/claim/clm_FF0B951718FB.md) - 2017-09-30 to 2018-03-31 | quarterly_research_and_development | 97,200,000 United States dollar | superseded | [clm_49182567CF43](/claim/clm_49182567CF43.md) - 2017-09-30 to 2017-12-31 | cash_and_equivalents | 422,700,000 United States dollar | superseded | [clm_68C3C8C3A783](/claim/clm_68C3C8C3A783.md) - 2017-09-30 to 2018-03-31 | quarterly_net_income | -14,100,000 United States dollar | superseded | [clm_6E3C280F62BC](/claim/clm_6E3C280F62BC.md) - 2017-09-30 to 2018-03-31 | quarterly_operating_income | -16,300,000 United States dollar | superseded | [clm_A53E519F7661](/claim/clm_A53E519F7661.md) - 2017-09-30 to 2018-03-31 | quarterly_revenue | 286,700,000 United States dollar | superseded | [clm_AD24E05F87CD](/claim/clm_AD24E05F87CD.md) - 2017-12-31 to 2018-03-31 | cash_and_equivalents | 430,000,000 United States dollar | superseded | [clm_108C34A6263F](/claim/clm_108C34A6263F.md) - 2017-12-31 to 2018-12-31 | revenue | 1,106,800,000 United States dollar | superseded | [clm_28D25724D93D](/claim/clm_28D25724D93D.md) - 2017-12-31 to 2018-12-31 | operating_income | -113,700,000 United States dollar | superseded | [clm_3290A265C391](/claim/clm_3290A265C391.md) - 2017-12-31 to 2018-03-31 | total_equity | 102,900,000 United States dollar | superseded | [clm_33A832B330DF](/claim/clm_33A832B330DF.md) - 2017-12-31 to 2018-03-31 | total_assets | 1,019,900,000 United States dollar | superseded | [clm_A4A637F8EC25](/claim/clm_A4A637F8EC25.md) - 2017-12-31 to 2018-12-31 | net_income | -111,700,000 United States dollar | superseded | [clm_C8AE11867198](/claim/clm_C8AE11867198.md) - 2017-12-31 to 2018-12-31 | research_and_development | 380,300,000 United States dollar | superseded | [clm_DB7DB6B4B716](/claim/clm_DB7DB6B4B716.md) ## 2018 - 2018-01-01 | listed_on | Nasdaq | valid | [clm_53218663C8BA](/claim/clm_53218663C8BA.md) - 2018-03-31 to 2018-06-30 | quarterly_net_income | -465,500,000 United States dollar | superseded | [clm_351D84DA9525](/claim/clm_351D84DA9525.md) - 2018-03-31 to 2018-06-30 | cash_and_equivalents | 665,300,000 United States dollar | superseded | [clm_438C002F1120](/claim/clm_438C002F1120.md) - 2018-03-31 to 2018-06-30 | quarterly_operating_income | -465,900,000 United States dollar | superseded | [clm_4FA10DCBDC0E](/claim/clm_4FA10DCBDC0E.md) - 2018-03-31 to 2018-06-30 | total_assets | 1,438,700,000 United States dollar | superseded | [clm_61605778B961](/claim/clm_61605778B961.md) - 2018-03-31 to 2018-06-30 | quarterly_revenue | 316,300,000 United States dollar | superseded | [clm_BB1C54AE2A8E](/claim/clm_BB1C54AE2A8E.md) - 2018-03-31 to 2018-06-30 | total_equity | 510,200,000 United States dollar | superseded | [clm_D168817BCA9D](/claim/clm_D168817BCA9D.md) - 2018-03-31 to 2018-06-30 | quarterly_research_and_development | 378,500,000 United States dollar | superseded | [clm_F402B93DA1EC](/claim/clm_F402B93DA1EC.md) - 2018-06-30 to 2018-09-30 | cash_and_equivalents | 504,100,000 United States dollar | superseded | [clm_11724EA59FEA](/claim/clm_11724EA59FEA.md) - 2018-06-30 to 2018-09-30 | quarterly_net_income | -4,100,000 United States dollar | superseded | [clm_18D1DF7568D3](/claim/clm_18D1DF7568D3.md) - 2018-06-30 to 2018-09-30 | quarterly_research_and_development | 119,700,000 United States dollar | superseded | [clm_2BD126E384AF](/claim/clm_2BD126E384AF.md) - 2018-06-30 to 2018-09-30 | quarterly_operating_income | -7,200,000 United States dollar | superseded | [clm_2DBAE5857BD1](/claim/clm_2DBAE5857BD1.md) - 2018-06-30 to 2018-09-30 | total_equity | 630,900,000 United States dollar | superseded | [clm_64BFD01BFDB4](/claim/clm_64BFD01BFDB4.md) - 2018-06-30 to 2018-09-30 | total_assets | 1,602,400,000 United States dollar | superseded | [clm_CF642E9DA7BE](/claim/clm_CF642E9DA7BE.md) - 2018-06-30 to 2018-09-30 | quarterly_revenue | 339,200,000 United States dollar | superseded | [clm_D3C8442DC474](/claim/clm_D3C8442DC474.md) - 2018-09-30 to 2019-03-31 | quarterly_operating_income | -8,900,000 United States dollar | superseded | [clm_13875809B3F2](/claim/clm_13875809B3F2.md) - 2018-09-30 to 2018-12-31 | total_assets | 1,623,100,000 United States dollar | superseded | [clm_4B02D5A26F18](/claim/clm_4B02D5A26F18.md) - 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 133,200,000 United States dollar | superseded | [clm_58CE514623C4](/claim/clm_58CE514623C4.md) - 2018-09-30 to 2018-12-31 | total_equity | 643,400,000 United States dollar | superseded | [clm_61BDAEBFF3D3](/claim/clm_61BDAEBFF3D3.md) - 2018-09-30 to 2019-03-31 | quarterly_net_income | -5,800,000 United States dollar | superseded | [clm_7768F94D5D6E](/claim/clm_7768F94D5D6E.md) - 2018-09-30 to 2019-03-31 | quarterly_revenue | 360,300,000 United States dollar | superseded | [clm_99ECF8953E30](/claim/clm_99ECF8953E30.md) - 2018-09-30 to 2018-12-31 | cash_and_equivalents | 536,200,000 United States dollar | superseded | [clm_D81CC63D751A](/claim/clm_D81CC63D751A.md) - 2018-12-31 to 2019-12-31 | revenue | 1,391,700,000 United States dollar | superseded | [clm_0CE69E88C921](/claim/clm_0CE69E88C921.md) - 2018-12-31 to 2019-12-31 | research_and_development | 768,200,000 United States dollar | superseded | [clm_17396FBA221B](/claim/clm_17396FBA221B.md) - 2018-12-31 to 2019-12-31 | net_income | -484,900,000 United States dollar | superseded | [clm_70A645A46FF7](/claim/clm_70A645A46FF7.md) - 2018-12-31 to 2019-03-31 | total_assets | 1,694,100,000 United States dollar | superseded | [clm_7E3F278085FF](/claim/clm_7E3F278085FF.md) - 2018-12-31 to 2019-12-31 | operating_income | -494,000,000 United States dollar | superseded | [clm_8CB90C372C90](/claim/clm_8CB90C372C90.md) - 2018-12-31 to 2019-03-31 | cash_and_equivalents | 519,300,000 United States dollar | superseded | [clm_9210ABA2FC16](/claim/clm_9210ABA2FC16.md) - 2018-12-31 to 2019-03-31 | total_equity | 676,800,000 United States dollar | superseded | [clm_E15907355B04](/claim/clm_E15907355B04.md) ## 2019 - 2019-03-31 to 2019-06-30 | quarterly_revenue | 385,600,000 United States dollar | superseded | [clm_05EBBF4AD725](/claim/clm_05EBBF4AD725.md) - 2019-03-31 to 2019-06-30 | quarterly_net_income | -7,700,000 United States dollar | superseded | [clm_37EC59BCA466](/claim/clm_37EC59BCA466.md) - 2019-03-31 to 2019-06-30 | quarterly_operating_income | -21,300,000 United States dollar | superseded | [clm_4475BE4631EA](/claim/clm_4475BE4631EA.md) - 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 150,000,000 United States dollar | superseded | [clm_45618045C246](/claim/clm_45618045C246.md) - 2019-03-31 to 2019-06-30 | total_equity | 704,900,000 United States dollar | superseded | [clm_6FFEF1A6A199](/claim/clm_6FFEF1A6A199.md) - 2019-03-31 to 2019-06-30 | cash_and_equivalents | 359,200,000 United States dollar | superseded | [clm_8D945379BBE3](/claim/clm_8D945379BBE3.md) - 2019-03-31 to 2019-06-30 | total_assets | 2,128,600,000 United States dollar | superseded | [clm_96C09E68C8E2](/claim/clm_96C09E68C8E2.md) - 2019-06-30 to 2019-09-30 | quarterly_operating_income | -34,000,000 United States dollar | superseded | [clm_0BBF392255C6](/claim/clm_0BBF392255C6.md) - 2019-06-30 to 2019-09-30 | total_assets | 2,364,900,000 United States dollar | superseded | [clm_3E7A673912B9](/claim/clm_3E7A673912B9.md) - 2019-06-30 to 2019-09-30 | cash_and_equivalents | 343,600,000 United States dollar | superseded | [clm_62681355863F](/claim/clm_62681355863F.md) - 2019-06-30 to 2019-09-30 | total_equity | 730,200,000 United States dollar | superseded | [clm_741A215A63D3](/claim/clm_741A215A63D3.md) - 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 162,400,000 United States dollar | superseded | [clm_A7628D8ABA0A](/claim/clm_A7628D8ABA0A.md) - 2019-06-30 to 2019-09-30 | quarterly_revenue | 401,500,000 United States dollar | superseded | [clm_F6B4CD49AE79](/claim/clm_F6B4CD49AE79.md) - 2019-06-30 to 2019-09-30 | quarterly_net_income | -21,400,000 United States dollar | superseded | [clm_FB10FB501909](/claim/clm_FB10FB501909.md) - 2019-09-30 to 2019-12-31 | cash_and_equivalents | 443,200,000 United States dollar | superseded | [clm_3E63A340373F](/claim/clm_3E63A340373F.md) - 2019-09-30 to 2020-03-31 | quarterly_net_income | -17,000,000 United States dollar | superseded | [clm_555B97996364](/claim/clm_555B97996364.md) - 2019-09-30 to 2019-12-31 | total_assets | 2,486,600,000 United States dollar | superseded | [clm_7F01E1EB795B](/claim/clm_7F01E1EB795B.md) - 2019-09-30 to 2019-12-31 | total_equity | 762,600,000 United States dollar | superseded | [clm_AC87977D86F7](/claim/clm_AC87977D86F7.md) - 2019-09-30 to 2020-03-31 | quarterly_operating_income | -18,600,000 United States dollar | superseded | [clm_C08180E88A8A](/claim/clm_C08180E88A8A.md) - 2019-09-30 to 2020-03-31 | quarterly_revenue | 428,200,000 United States dollar | superseded | [clm_F40B3B32F5F7](/claim/clm_F40B3B32F5F7.md) - 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 172,800,000 United States dollar | superseded | [clm_FF7EE2CEACE6](/claim/clm_FF7EE2CEACE6.md) - 2019-12-31 to 2020-03-31 | total_equity | 808,400,000 United States dollar | superseded | [clm_17F2C8A8F058](/claim/clm_17F2C8A8F058.md) - 2019-12-31 to 2020-12-31 | net_income | -52,700,000 United States dollar | superseded | [clm_1D1391D68649](/claim/clm_1D1391D68649.md) - 2019-12-31 to 2020-12-31 | research_and_development | 662,100,000 United States dollar | superseded | [clm_33E89568C09D](/claim/clm_33E89568C09D.md) - 2019-12-31 to 2020-03-31 | cash_and_equivalents | 551,300,000 United States dollar | superseded | [clm_ADDDC5240A98](/claim/clm_ADDDC5240A98.md) - 2019-12-31 to 2020-12-31 | revenue | 1,661,300,000 United States dollar | superseded | [clm_D426F6E66378](/claim/clm_D426F6E66378.md) - 2019-12-31 to 2020-03-31 | total_assets | 2,699,200,000 United States dollar | superseded | [clm_E429776BA78A](/claim/clm_E429776BA78A.md) - 2019-12-31 to 2020-12-31 | operating_income | -80,500,000 United States dollar | superseded | [clm_EA70F4727B86](/claim/clm_EA70F4727B86.md) ## 2020 - 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 181,800,000 United States dollar | superseded | [clm_08D8956406D1](/claim/clm_08D8956406D1.md) - 2020-03-31 to 2020-06-30 | total_equity | 800,400,000 United States dollar | superseded | [clm_7F519A87FC7D](/claim/clm_7F519A87FC7D.md) - 2020-03-31 to 2020-06-30 | total_assets | 2,717,300,000 United States dollar | superseded | [clm_9999C2A0506B](/claim/clm_9999C2A0506B.md) - 2020-03-31 to 2020-06-30 | quarterly_net_income | 39,300,000 United States dollar | superseded | [clm_BA908944A275](/claim/clm_BA908944A275.md) - 2020-03-31 to 2020-06-30 | quarterly_operating_income | 26,800,000 United States dollar | superseded | [clm_BD89E046761E](/claim/clm_BD89E046761E.md) - 2020-03-31 to 2020-06-30 | cash_and_equivalents | 486,400,000 United States dollar | superseded | [clm_D07827FEB203](/claim/clm_D07827FEB203.md) - 2020-03-31 to 2020-06-30 | quarterly_revenue | 455,000,000 United States dollar | superseded | [clm_E01F258AB91B](/claim/clm_E01F258AB91B.md) - 2020-06-30 to 2020-09-30 | quarterly_operating_income | 12,800,000 United States dollar | superseded | [clm_4BC4EBE79429](/claim/clm_4BC4EBE79429.md) - 2020-06-30 to 2020-09-30 | quarterly_net_income | 17,500,000 United States dollar | superseded | [clm_54B6CF7B49FB](/claim/clm_54B6CF7B49FB.md) - 2020-06-30 to 2020-09-30 | quarterly_revenue | 467,400,000 United States dollar | superseded | [clm_64C5EDDC4912](/claim/clm_64C5EDDC4912.md) - 2020-06-30 to 2020-09-30 | cash_and_equivalents | 334,200,000 United States dollar | superseded | [clm_65B9EE402060](/claim/clm_65B9EE402060.md) - 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 185,800,000 United States dollar | superseded | [clm_A22FB5D140CA](/claim/clm_A22FB5D140CA.md) - 2020-06-30 to 2020-09-30 | total_assets | 2,742,300,000 United States dollar | superseded | [clm_CD826E8399EB](/claim/clm_CD826E8399EB.md) - 2020-06-30 to 2020-09-30 | total_equity | 803,400,000 United States dollar | superseded | [clm_E8A100D2B0F5](/claim/clm_E8A100D2B0F5.md) - 2020-09-30 to 2020-12-31 | total_assets | 2,862,300,000 United States dollar | superseded | [clm_120DA9AA2B3F](/claim/clm_120DA9AA2B3F.md) - 2020-09-30 to 2020-12-31 | total_equity | 851,300,000 United States dollar | superseded | [clm_37EA84863381](/claim/clm_37EA84863381.md) - 2020-09-30 to 2021-03-31 | quarterly_net_income | 32,700,000 United States dollar | superseded | [clm_3B412D089CF6](/claim/clm_3B412D089CF6.md) - 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 183,300,000 United States dollar | superseded | [clm_516BC191B9ED](/claim/clm_516BC191B9ED.md) - 2020-09-30 to 2020-12-31 | cash_and_equivalents | 452,700,000 United States dollar | superseded | [clm_586F1324FC62](/claim/clm_586F1324FC62.md) - 2020-09-30 to 2021-03-31 | quarterly_operating_income | 30,000,000 United States dollar | superseded | [clm_7F7B18058552](/claim/clm_7F7B18058552.md) - 2020-09-30 to 2021-03-31 | quarterly_revenue | 487,400,000 United States dollar | superseded | [clm_F0887BE80B60](/claim/clm_F0887BE80B60.md) - 2020-12-31 to 2021-03-31 | total_equity | 333,800,000 United States dollar | superseded | [clm_03B957364DF0](/claim/clm_03B957364DF0.md) - 2020-12-31 to 2021-03-31 | total_assets | 2,387,200,000 United States dollar | superseded | [clm_08ED57F44A3D](/claim/clm_08ED57F44A3D.md) - 2020-12-31 to 2021-12-31 | operating_income | -277,000,000 United States dollar | superseded | [clm_3263AB4CCC86](/claim/clm_3263AB4CCC86.md) - 2020-12-31 to 2021-12-31 | research_and_development | 727,500,000 United States dollar | superseded | [clm_623B2E60D537](/claim/clm_623B2E60D537.md) - 2020-12-31 to 2021-12-31 | net_income | -256,300,000 United States dollar | superseded | [clm_8B737F4B7CBF](/claim/clm_8B737F4B7CBF.md) - 2020-12-31 to 2021-03-31 | cash_and_equivalents | 314,900,000 United States dollar | superseded | [clm_E3D618943902](/claim/clm_E3D618943902.md) - 2020-12-31 to 2021-12-31 | revenue | 1,913,900,000 United States dollar | superseded | [clm_E7A9DAFD6390](/claim/clm_E7A9DAFD6390.md) ## 2021 - 2021-03-31 to 2021-06-30 | quarterly_revenue | 511,600,000 United States dollar | superseded | [clm_3D82C9B389FF](/claim/clm_3D82C9B389FF.md) - 2021-03-31 to 2021-06-30 | total_assets | 3,307,300,000 United States dollar | superseded | [clm_4D525C376F10](/claim/clm_4D525C376F10.md) - 2021-03-31 to 2021-06-30 | cash_and_equivalents | 845,500,000 United States dollar | superseded | [clm_9A1B2F5482FB](/claim/clm_9A1B2F5482FB.md) - 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 181,200,000 United States dollar | superseded | [clm_9D424D18375C](/claim/clm_9D424D18375C.md) - 2021-03-31 to 2021-06-30 | quarterly_operating_income | 42,500,000 United States dollar | superseded | [clm_E1A428E64350](/claim/clm_E1A428E64350.md) - 2021-03-31 to 2021-06-30 | quarterly_net_income | 47,600,000 United States dollar | superseded | [clm_FA5841E60B21](/claim/clm_FA5841E60B21.md) - 2021-03-31 to 2021-06-30 | total_equity | -83,000,000 United States dollar | superseded | [clm_FC9DC4D6343D](/claim/clm_FC9DC4D6343D.md) - 2021-06-30 to 2021-09-30 | total_assets | 3,328,100,000 United States dollar | superseded | [clm_1479096AC10D](/claim/clm_1479096AC10D.md) - 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 185,500,000 United States dollar | superseded | [clm_46FBE546434A](/claim/clm_46FBE546434A.md) - 2021-06-30 to 2021-09-30 | quarterly_revenue | 530,600,000 United States dollar | superseded | [clm_5C43839B344C](/claim/clm_5C43839B344C.md) - 2021-06-30 to 2021-09-30 | cash_and_equivalents | 885,300,000 United States dollar | superseded | [clm_9FAA30B05AE6](/claim/clm_9FAA30B05AE6.md) - 2021-06-30 to 2021-09-30 | total_equity | -94,800,000 United States dollar | superseded | [clm_B7BCF98F0E58](/claim/clm_B7BCF98F0E58.md) - 2021-06-30 to 2021-09-30 | quarterly_net_income | 88,000,000 United States dollar | superseded | [clm_C25EAAEBBFEC](/claim/clm_C25EAAEBBFEC.md) - 2021-06-30 to 2021-09-30 | quarterly_operating_income | 84,400,000 United States dollar | superseded | [clm_EFFDB5AC170A](/claim/clm_EFFDB5AC170A.md) - 2021-09-30 to 2021-12-31 | total_equity | -162,600,000 United States dollar | superseded | [clm_059FDEDA2ED2](/claim/clm_059FDEDA2ED2.md) - 2021-09-30 to 2022-03-31 | quarterly_net_income | 75,600,000 United States dollar | superseded | [clm_281E1F6FADE3](/claim/clm_281E1F6FADE3.md) - 2021-09-30 to 2022-03-31 | quarterly_operating_income | 77,300,000 United States dollar | superseded | [clm_646D28E56976](/claim/clm_646D28E56976.md) - 2021-09-30 to 2021-12-31 | cash_and_equivalents | 688,900,000 United States dollar | superseded | [clm_7A9D1E598CB3](/claim/clm_7A9D1E598CB3.md) - 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 187,300,000 United States dollar | superseded | [clm_C40A55B292BD](/claim/clm_C40A55B292BD.md) - 2021-09-30 to 2022-03-31 | quarterly_revenue | 550,200,000 United States dollar | superseded | [clm_E1EF9C1643D2](/claim/clm_E1EF9C1643D2.md) - 2021-09-30 to 2021-12-31 | total_assets | 3,339,100,000 United States dollar | superseded | [clm_FB9B05F5987F](/claim/clm_FB9B05F5987F.md) - 2021-12-31 to 2022-12-31 | research_and_development | 755,900,000 United States dollar | superseded | [clm_17F7ABFEEF91](/claim/clm_17F7ABFEEF91.md) - 2021-12-31 to 2022-03-31 | total_equity | -293,900,000 United States dollar | superseded | [clm_5E9B0BC5171D](/claim/clm_5E9B0BC5171D.md) - 2021-12-31 to 2022-12-31 | operating_income | 274,400,000 United States dollar | superseded | [clm_698DBFFD439A](/claim/clm_698DBFFD439A.md) - 2021-12-31 to 2022-12-31 | net_income | 335,800,000 United States dollar | superseded | [clm_77EA75E93B56](/claim/clm_77EA75E93B56.md) - 2021-12-31 to 2022-03-31 | total_assets | 3,091,300,000 United States dollar | superseded | [clm_913988A58C29](/claim/clm_913988A58C29.md) - 2021-12-31 to 2022-12-31 | revenue | 2,157,900,000 United States dollar | superseded | [clm_D1173DB153E2](/claim/clm_D1173DB153E2.md) - 2021-12-31 to 2022-03-31 | cash_and_equivalents | 533,000,000 United States dollar | superseded | [clm_D4738B36140F](/claim/clm_D4738B36140F.md) ## 2022 - 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 210,800,000 United States dollar | superseded | [clm_0D21A65929DE](/claim/clm_0D21A65929DE.md) - 2022-03-31 to 2022-06-30 | quarterly_net_income | 79,700,000 United States dollar | superseded | [clm_216F34C14EBB](/claim/clm_216F34C14EBB.md) - 2022-03-31 to 2022-06-30 | cash_and_equivalents | 445,500,000 United States dollar | superseded | [clm_3C05F2C1AC24](/claim/clm_3C05F2C1AC24.md) - 2022-03-31 to 2022-06-30 | quarterly_revenue | 562,400,000 United States dollar | superseded | [clm_5C7BC3DB7ABF](/claim/clm_5C7BC3DB7ABF.md) - 2022-03-31 to 2022-06-30 | total_equity | -463,300,000 United States dollar | superseded | [clm_B462D538907D](/claim/clm_B462D538907D.md) - 2022-03-31 to 2022-06-30 | quarterly_operating_income | 89,500,000 United States dollar | superseded | [clm_E3DDD9808FB6](/claim/clm_E3DDD9808FB6.md) - 2022-03-31 to 2022-06-30 | total_assets | 2,852,000,000 United States dollar | superseded | [clm_F95E3EDF4124](/claim/clm_F95E3EDF4124.md) - 2022-06-30 to 2022-09-30 | quarterly_revenue | 572,700,000 United States dollar | superseded | [clm_138069B882B4](/claim/clm_138069B882B4.md) - 2022-06-30 to 2022-09-30 | quarterly_operating_income | 82,900,000 United States dollar | superseded | [clm_16414D7E1FA3](/claim/clm_16414D7E1FA3.md) - 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 215,000,000 United States dollar | superseded | [clm_837640AD1E79](/claim/clm_837640AD1E79.md) - 2022-06-30 to 2022-09-30 | cash_and_equivalents | 352,100,000 United States dollar | superseded | [clm_9901340C6509](/claim/clm_9901340C6509.md) - 2022-06-30 to 2022-09-30 | total_equity | -542,900,000 United States dollar | superseded | [clm_A01490A3D802](/claim/clm_A01490A3D802.md) - 2022-06-30 to 2022-09-30 | quarterly_net_income | 62,000,000 United States dollar | superseded | [clm_CA28FAAE954B](/claim/clm_CA28FAAE954B.md) - 2022-06-30 to 2022-09-30 | total_assets | 2,758,800,000 United States dollar | superseded | [clm_DB341D4EE03B](/claim/clm_DB341D4EE03B.md) - 2022-09-30 to 2022-12-31 | cash_and_equivalents | 372,000,000 United States dollar | superseded | [clm_09CDBC8E2AA4](/claim/clm_09CDBC8E2AA4.md) - 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 227,600,000 United States dollar | superseded | [clm_0CDBA650D14A](/claim/clm_0CDBA650D14A.md) - 2022-09-30 to 2023-03-31 | quarterly_net_income | 83,200,000 United States dollar | superseded | [clm_32161249B2E1](/claim/clm_32161249B2E1.md) - 2022-09-30 to 2022-12-31 | total_equity | -591,300,000 United States dollar | superseded | [clm_5BA416F5012D](/claim/clm_5BA416F5012D.md) - 2022-09-30 to 2022-12-31 | total_assets | 2,702,800,000 United States dollar | superseded | [clm_679C753C11A7](/claim/clm_679C753C11A7.md) - 2022-09-30 to 2023-03-31 | quarterly_revenue | 591,000,000 United States dollar | superseded | [clm_B26BE12F707E](/claim/clm_B26BE12F707E.md) - 2022-09-30 to 2023-03-31 | quarterly_operating_income | 89,300,000 United States dollar | superseded | [clm_B8066A95C834](/claim/clm_B8066A95C834.md) - 2022-12-31 to 2023-12-31 | operating_income | 181,300,000 United States dollar | superseded | [clm_01B609E7DD0D](/claim/clm_01B609E7DD0D.md) - 2022-12-31 to 2023-03-31 | total_equity | -309,400,000 United States dollar | superseded | [clm_1AEFC80D9D57](/claim/clm_1AEFC80D9D57.md) - 2022-12-31 to 2023-12-31 | revenue | 2,324,900,000 United States dollar | superseded | [clm_21DF57FBA6F0](/claim/clm_21DF57FBA6F0.md) - 2022-12-31 to 2023-03-31 | cash_and_equivalents | 232,800,000 United States dollar | superseded | [clm_4DAE3B7ABF49](/claim/clm_4DAE3B7ABF49.md) - 2022-12-31 to 2023-03-31 | total_assets | 3,110,100,000 United States dollar | superseded | [clm_7F8910B1B3EC](/claim/clm_7F8910B1B3EC.md) - 2022-12-31 to 2023-12-31 | net_income | 553,200,000 United States dollar | superseded | [clm_B17878351889](/claim/clm_B17878351889.md) - 2022-12-31 to 2023-12-31 | research_and_development | 891,900,000 United States dollar | superseded | [clm_EE94B581160B](/claim/clm_EE94B581160B.md) ## 2023 - 2023-03-31 to 2023-06-30 | cash_and_equivalents | 332,700,000 United States dollar | superseded | [clm_0359D344FAA6](/claim/clm_0359D344FAA6.md) - 2023-03-31 to 2023-06-30 | total_assets | 2,993,700,000 United States dollar | superseded | [clm_45CB30488FB6](/claim/clm_45CB30488FB6.md) - 2023-03-31 to 2023-06-30 | quarterly_revenue | 611,100,000 United States dollar | superseded | [clm_4681DC0B2599](/claim/clm_4681DC0B2599.md) - 2023-03-31 to 2023-06-30 | quarterly_operating_income | 84,100,000 United States dollar | superseded | [clm_55E06BEF487B](/claim/clm_55E06BEF487B.md) - 2023-03-31 to 2023-06-30 | total_equity | -365,200,000 United States dollar | superseded | [clm_77B58F0029C5](/claim/clm_77B58F0029C5.md) - 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 235,200,000 United States dollar | superseded | [clm_960198B2935C](/claim/clm_960198B2935C.md) - 2023-03-31 to 2023-06-30 | quarterly_net_income | 69,000,000 United States dollar | superseded | [clm_C34CD309092A](/claim/clm_C34CD309092A.md) - 2023-06-30 to 2023-09-30 | total_equity | -411,900,000 United States dollar | superseded | [clm_3EA1E5438456](/claim/clm_3EA1E5438456.md) - 2023-06-30 to 2023-09-30 | quarterly_operating_income | 56,500,000 United States dollar | superseded | [clm_544C7F744FFC](/claim/clm_544C7F744FFC.md) - 2023-06-30 to 2023-09-30 | total_assets | 2,938,600,000 United States dollar | superseded | [clm_79345E5038E7](/claim/clm_79345E5038E7.md) - 2023-06-30 to 2023-09-30 | quarterly_revenue | 622,500,000 United States dollar | superseded | [clm_7EB9F9B3F341](/claim/clm_7EB9F9B3F341.md) - 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 262,800,000 United States dollar | superseded | [clm_A1AC12757A46](/claim/clm_A1AC12757A46.md) - 2023-06-30 to 2023-09-30 | cash_and_equivalents | 510,300,000 United States dollar | superseded | [clm_BD15FE4C4A31](/claim/clm_BD15FE4C4A31.md) - 2023-06-30 to 2023-09-30 | quarterly_net_income | 43,200,000 United States dollar | superseded | [clm_F94DC854354B](/claim/clm_F94DC854354B.md) - 2023-09-30 to 2023-12-31 | total_equity | -350,300,000 United States dollar | superseded | [clm_19A72ED5310B](/claim/clm_19A72ED5310B.md) - 2023-09-30 to 2024-03-31 | quarterly_operating_income | 130,700,000 United States dollar | superseded | [clm_361B14ECB037](/claim/clm_361B14ECB037.md) - 2023-09-30 to 2023-12-31 | cash_and_equivalents | 604,300,000 United States dollar | superseded | [clm_3F0B61A4E086](/claim/clm_3F0B61A4E086.md) - 2023-09-30 to 2024-03-31 | quarterly_revenue | 633,000,000 United States dollar | superseded | [clm_5CBD18B9E5C8](/claim/clm_5CBD18B9E5C8.md) - 2023-09-30 to 2024-03-31 | quarterly_net_income | 114,100,000 United States dollar | superseded | [clm_63C1647C0CC1](/claim/clm_63C1647C0CC1.md) - 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 216,400,000 United States dollar | superseded | [clm_A85622C16EA4](/claim/clm_A85622C16EA4.md) - 2023-09-30 to 2023-12-31 | total_assets | 3,010,600,000 United States dollar | superseded | [clm_CF1E4BD67516](/claim/clm_CF1E4BD67516.md) - 2023-12-13 | board_member | Andrew Moore | valid | [clm_4FCE6A79F165](/claim/clm_4FCE6A79F165.md) - 2023-12-31 to 2024-12-31 | operating_income | 538,700,000 United States dollar | superseded | [clm_2545632DB768](/claim/clm_2545632DB768.md) - 2023-12-31 to 2024-12-31 | net_income | 453,600,000 United States dollar | superseded | [clm_261BC431751C](/claim/clm_261BC431751C.md) - 2023-12-31 to 2024-12-31 | research_and_development | 936,500,000 United States dollar | superseded | [clm_29AFDA68895E](/claim/clm_29AFDA68895E.md) - 2023-12-31 to 2024-03-31 | total_assets | 2,983,500,000 United States dollar | superseded | [clm_87F913DF7EBE](/claim/clm_87F913DF7EBE.md) - 2023-12-31 to 2024-03-31 | cash_and_equivalents | 614,900,000 United States dollar | superseded | [clm_9CA7AEE2F5D4](/claim/clm_9CA7AEE2F5D4.md) - 2023-12-31 to 2024-03-31 | total_equity | -165,800,000 United States dollar | superseded | [clm_9EDC2398073A](/claim/clm_9EDC2398073A.md) - 2023-12-31 to 2024-12-31 | revenue | 2,501,600,000 United States dollar | superseded | [clm_CB25867AD9A9](/claim/clm_CB25867AD9A9.md) ## 2024 - 2024-03-31 to 2024-06-30 | quarterly_operating_income | 143,500,000 United States dollar | superseded | [clm_2243A701F9DB](/claim/clm_2243A701F9DB.md) - 2024-03-31 to 2024-06-30 | quarterly_revenue | 631,300,000 United States dollar | superseded | [clm_3933DFCC49F8](/claim/clm_3933DFCC49F8.md) - 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 219,100,000 United States dollar | superseded | [clm_88302E9B4858](/claim/clm_88302E9B4858.md) - 2024-03-31 to 2024-06-30 | cash_and_equivalents | 548,900,000 United States dollar | superseded | [clm_8B19FF1F217D](/claim/clm_8B19FF1F217D.md) - 2024-03-31 to 2024-06-30 | quarterly_net_income | 132,300,000 United States dollar | superseded | [clm_90F1B8127A5D](/claim/clm_90F1B8127A5D.md) - 2024-03-31 to 2024-06-30 | total_assets | 2,797,700,000 United States dollar | superseded | [clm_B2B4621BA976](/claim/clm_B2B4621BA976.md) - 2024-03-31 to 2024-06-30 | total_equity | -277,200,000 United States dollar | superseded | [clm_CEB94FA13961](/claim/clm_CEB94FA13961.md) - 2024-06-30 to 2024-09-30 | total_assets | 2,718,500,000 United States dollar | superseded | [clm_23FAF79C23FA](/claim/clm_23FAF79C23FA.md) - 2024-06-30 to 2024-09-30 | total_equity | -371,300,000 United States dollar | superseded | [clm_83797D97668B](/claim/clm_83797D97668B.md) - 2024-06-30 to 2024-09-30 | quarterly_net_income | 110,500,000 United States dollar | superseded | [clm_B3C3864D0492](/claim/clm_B3C3864D0492.md) - 2024-06-30 to 2024-09-30 | quarterly_operating_income | 127,000,000 United States dollar | superseded | [clm_BE9139B84918](/claim/clm_BE9139B84918.md) - 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 227,100,000 United States dollar | superseded | [clm_C4EF40100A2A](/claim/clm_C4EF40100A2A.md) - 2024-06-30 to 2024-09-30 | cash_and_equivalents | 515,100,000 United States dollar | superseded | [clm_E15E28BA64FD](/claim/clm_E15E28BA64FD.md) - 2024-06-30 to 2024-09-30 | quarterly_revenue | 634,500,000 United States dollar | superseded | [clm_FDFC3824FBC7](/claim/clm_FDFC3824FBC7.md) - 2024-09-30 to 2024-12-31 | total_assets | 2,576,700,000 United States dollar | superseded | [clm_094D4C184788](/claim/clm_094D4C184788.md) - 2024-09-30 to 2024-12-31 | cash_and_equivalents | 517,600,000 United States dollar | superseded | [clm_279CC45CB5C3](/claim/clm_279CC45CB5C3.md) - 2024-09-30 to 2025-03-31 | quarterly_operating_income | 127,800,000 United States dollar | superseded | [clm_3632D8AE1D2E](/claim/clm_3632D8AE1D2E.md) - 2024-09-30 to 2024-12-31 | total_equity | -546,100,000 United States dollar | superseded | [clm_770D60418204](/claim/clm_770D60418204.md) - 2024-09-30 to 2025-03-31 | quarterly_revenue | 638,800,000 United States dollar | superseded | [clm_9E2B53D3956F](/claim/clm_9E2B53D3956F.md) - 2024-09-30 to 2025-03-31 | quarterly_net_income | 106,700,000 United States dollar | superseded | [clm_A0B3D3CFF8D4](/claim/clm_A0B3D3CFF8D4.md) - 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 225,700,000 United States dollar | superseded | [clm_B0CD304C9B1F](/claim/clm_B0CD304C9B1F.md) - 2024-10-30 | restructuring | Reduce global workforce by about 20% to streamline team structure. | valid | [clm_63B69B6B53DA](/claim/clm_63B69B6B53DA.md) - 2024-12-31 to 2025-12-31 | revenue | 2,548,200,000 United States dollar | superseded | [clm_56939901898E](/claim/clm_56939901898E.md) - 2024-12-31 to 2025-12-31 | net_income | 452,300,000 United States dollar | superseded | [clm_64FDF287C5AD](/claim/clm_64FDF287C5AD.md) - 2024-12-31 to 2025-03-31 | total_assets | 3,325,200,000 United States dollar | superseded | [clm_9194751B6266](/claim/clm_9194751B6266.md) - 2024-12-31 to 2025-12-31 | research_and_development | 914,900,000 United States dollar | superseded | [clm_9640EE478669](/claim/clm_9640EE478669.md) - 2024-12-31 to 2025-03-31 | cash_and_equivalents | 1,328,300,000 United States dollar | superseded | [clm_AFF5554DFEA3](/claim/clm_AFF5554DFEA3.md) - 2024-12-31 to 2025-03-31 | total_equity | -752,400,000 United States dollar | superseded | [clm_BBE74561F25C](/claim/clm_BBE74561F25C.md) - 2024-12-31 to 2025-12-31 | operating_income | 486,200,000 United States dollar | superseded | [clm_E16C06C665F8](/claim/clm_E16C06C665F8.md) ## 2025 - 2025-01-17 | board_member | Warren Jenson | valid | [clm_739B25E75F92](/claim/clm_739B25E75F92.md) - 2025-03-31 to 2025-06-30 | quarterly_net_income | 150,300,000 United States dollar | superseded | [clm_32F4CDD16C9C](/claim/clm_32F4CDD16C9C.md) - 2025-03-31 to 2025-06-30 | quarterly_operating_income | 183,800,000 United States dollar | superseded | [clm_6D781FE425E9](/claim/clm_6D781FE425E9.md) - 2025-03-31 to 2025-06-30 | quarterly_revenue | 624,700,000 United States dollar | superseded | [clm_9CB742CF3CA2](/claim/clm_9CB742CF3CA2.md) - 2025-03-31 to 2025-06-30 | total_assets | 2,957,300,000 United States dollar | superseded | [clm_AF0E5C5253D8](/claim/clm_AF0E5C5253D8.md) - 2025-03-31 to 2025-06-30 | total_equity | -1,075,700,000 United States dollar | superseded | [clm_B384972098D1](/claim/clm_B384972098D1.md) - 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 178,400,000 United States dollar | superseded | [clm_C759F81522D5](/claim/clm_C759F81522D5.md) - 2025-03-31 to 2025-06-30 | cash_and_equivalents | 942,200,000 United States dollar | superseded | [clm_F2D5EF35E6CC](/claim/clm_F2D5EF35E6CC.md) - 2025-06-30 to 2025-09-30 | quarterly_revenue | 625,700,000 United States dollar | superseded | [clm_2B2579ABF178](/claim/clm_2B2579ABF178.md) - 2025-06-30 to 2025-09-30 | total_equity | -1,305,500,000 United States dollar | superseded | [clm_65889AF85F54](/claim/clm_65889AF85F54.md) - 2025-06-30 to 2025-09-30 | quarterly_net_income | 125,600,000 United States dollar | superseded | [clm_692FA24E0C34](/claim/clm_692FA24E0C34.md) - 2025-06-30 to 2025-09-30 | total_assets | 2,779,400,000 United States dollar | superseded | [clm_B022E6B12ED2](/claim/clm_B022E6B12ED2.md) - 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 184,400,000 United States dollar | superseded | [clm_B5C19F434D96](/claim/clm_B5C19F434D96.md) - 2025-06-30 to 2025-09-30 | cash_and_equivalents | 736,300,000 United States dollar | superseded | [clm_BCCF39B9CAFA](/claim/clm_BCCF39B9CAFA.md) - 2025-06-30 to 2025-09-30 | quarterly_operating_income | 168,400,000 United States dollar | superseded | [clm_C973101272FC](/claim/clm_C973101272FC.md) - 2025-09-30 to 2025-12-31 | total_equity | -1,531,200,000 United States dollar | superseded | [clm_0A4A99DF66AA](/claim/clm_0A4A99DF66AA.md) - 2025-09-30 to 2026-03-31 | quarterly_net_income | 123,800,000 United States dollar | superseded | [clm_124717622F09](/claim/clm_124717622F09.md) - 2025-09-30 to 2026-03-31 | quarterly_revenue | 634,400,000 United States dollar | superseded | [clm_2259E43FFCE6](/claim/clm_2259E43FFCE6.md) - 2025-09-30 to 2025-12-31 | total_assets | 2,795,800,000 United States dollar | superseded | [clm_242D11E2AEB0](/claim/clm_242D11E2AEB0.md) - 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 182,300,000 United States dollar | superseded | [clm_9E12EDA5743E](/claim/clm_9E12EDA5743E.md) - 2025-09-30 to 2025-12-31 | cash_and_equivalents | 730,700,000 United States dollar | superseded | [clm_C3B90211C8A7](/claim/clm_C3B90211C8A7.md) - 2025-09-30 to 2026-03-31 | quarterly_operating_income | 174,700,000 United States dollar | superseded | [clm_DE48A4E9AA8E](/claim/clm_DE48A4E9AA8E.md) - 2025-12-16 | cfo | Ross Tennenbaum | valid | [clm_8666E3E9B889](/claim/clm_8666E3E9B889.md) - 2025-12-31 | operating_income | 689,100,000 United States dollar | valid | [clm_503F6C83BB11](/claim/clm_503F6C83BB11.md) - 2025-12-31 to 2026-03-31 | total_equity | -1,797,200,000 United States dollar | superseded | [clm_856896C361B6](/claim/clm_856896C361B6.md) - 2025-12-31 to 2026-03-31 | total_assets | 2,844,900,000 United States dollar | superseded | [clm_96EBC384FA30](/claim/clm_96EBC384FA30.md) - 2025-12-31 | revenue | 2,521,000,000 United States dollar | valid | [clm_9ACFCCB8228D](/claim/clm_9ACFCCB8228D.md) - 2025-12-31 | employees | 2,113 | valid | [clm_C2BAA22C0951](/claim/clm_C2BAA22C0951.md) - 2025-12-31 | net_income | 508,400,000 United States dollar | valid | [clm_D25483D65742](/claim/clm_D25483D65742.md) - 2025-12-31 to 2026-03-31 | cash_and_equivalents | 891,300,000 United States dollar | superseded | [clm_D661370C975B](/claim/clm_D661370C975B.md) - 2025-12-31 | research_and_development | 732,000,000 United States dollar | valid | [clm_F392A8EC0DA1](/claim/clm_F392A8EC0DA1.md) ## 2026 - 2026-03-31 to 2026-06-30 | quarterly_operating_income | 172,800,000 United States dollar | superseded | [clm_3F064D263C39](/claim/clm_3F064D263C39.md) - 2026-03-31 to 2026-06-30 | cash_and_equivalents | 1,207,400,000 United States dollar | superseded | [clm_4B42BE47CF92](/claim/clm_4B42BE47CF92.md) - 2026-03-31 to 2026-06-30 | quarterly_net_income | 114,500,000 United States dollar | superseded | [clm_4C1F3A20B298](/claim/clm_4C1F3A20B298.md) - 2026-03-31 to 2026-06-30 | total_assets | 3,030,900,000 United States dollar | superseded | [clm_5520F64DAA47](/claim/clm_5520F64DAA47.md) - 2026-03-31 to 2026-06-30 | quarterly_revenue | 629,500,000 United States dollar | superseded | [clm_5DED3FC62C54](/claim/clm_5DED3FC62C54.md) - 2026-03-31 to 2026-06-30 | total_equity | -2,011,700,000 United States dollar | superseded | [clm_89AC8DC2F996](/claim/clm_89AC8DC2F996.md) - 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 184,200,000 United States dollar | superseded | [clm_9A53DD908F6D](/claim/clm_9A53DD908F6D.md) - 2026-05-26 | board_member | Ashraf Alkarmi | valid | [clm_138D0702950C](/claim/clm_138D0702950C.md) - 2026-05-26 | ceo | Ashraf Alkarmi | valid | [clm_A51DDDF23DD9](/claim/clm_A51DDDF23DD9.md) - 2026-06-30 | total_equity | -2,188,300,000 United States dollar | valid | [clm_1FA9FD9C904D](/claim/clm_1FA9FD9C904D.md) - 2026-06-30 | quarterly_operating_income | 164,800,000 United States dollar | valid | [clm_6398B63F3168](/claim/clm_6398B63F3168.md) - 2026-06-30 | total_assets | 2,826,300,000 United States dollar | valid | [clm_78B0A76F388B](/claim/clm_78B0A76F388B.md) - 2026-06-30 | quarterly_net_income | 95,800,000 United States dollar | valid | [clm_8F34C2D93A32](/claim/clm_8F34C2D93A32.md) - 2026-06-30 | cash_and_equivalents | 1,056,200,000 United States dollar | valid | [clm_9FAFD734BB6A](/claim/clm_9FAFD734BB6A.md) - 2026-06-30 | quarterly_research_and_development | 188,100,000 United States dollar | valid | [clm_C83526994B2B](/claim/clm_C83526994B2B.md) - 2026-06-30 | quarterly_revenue | 631,500,000 United States dollar | valid | [clm_EE84F1297348](/claim/clm_EE84F1297348.md) - 2026-10-28 | restructuring | Reduce global workforce about 9% to align investments with top priorities. | valid | [clm_47C99A12EDBF](/claim/clm_47C99A12EDBF.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.